Literature DB >> 30101377

Hyperinsulinemia precedes insulin resistance in offspring rats exposed to angiotensin II type 1 autoantibody in utero.

Suli Zhang1, Mingming Wei1, Mingming Yue1, Pengli Wang1, Xiaochen Yin1, Li Wang2, Xiaoli Yang3, Huirong Liu4,5.   

Abstract

OBJECTIVE: Insulin resistance is highly associated with an adverse intrauterine environment. We previously reported that fetal rats exposed to angiotensin II type 1 receptor (AT1R) autoantibody (AT1-AA) displayed increased susceptibility to metabolic diseases during middle age. However, the timing of the onset of insulin resistance remains unknown. In this study, we examined the offspring of AT1-AA-positive rats, tracking the development of insulin resistance.
METHODS: Pregnant rats were intravenously injected with AT1-AA. Afterwards, we collected serum samples and liver tissues of the offspring at various stages, including gestation day 18, 3 weeks (weaning period), 18 weeks (young adulthood), and 48 weeks (middle age) after birth.
RESULTS: Compared with saline control group, hepatic vacuolar degeneration was visible in AT1-AA offspring rats as early as 3 weeks; hyperinsulinemia and impaired glucose tolerance occurred at 18 weeks of age, however, insulin resistance was not observed until 48 weeks. At 18 weeks we detected suppressed protein levels of insulin receptor (IR) but increased levels of IR substrate 1 (IRS1) in the liver of AT1-AA group rats. Interestingly, both IR and IRS1/2 were significantly decreased at 48 weeks. Liver proteomic analysis indicated that the differences in protein expression between the AT1-AA and control rats became more pronounced with age, particularly in terms of mitochondrial energy metabolism.
CONCLUSION: Rats exposed to AT1-AA in utero developed hyperinsulinemia from young adulthood which subsequently progressed to insulin resistance, and was linked with abnormal hepatic structure and impaired IR signaling. Additionally, dysregulation of energy metabolism may play a fundamental role in predisposing offspring to insulin resistance.

Entities:  

Keywords:  Angiotensin II type 1 receptor; Autoantibody; Insulin resistance; Liver; Offspring

Mesh:

Substances:

Year:  2018        PMID: 30101377     DOI: 10.1007/s12020-018-1700-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  28 in total

Review 1.  Mechanisms of insulin resistance in obesity.

Authors:  Jianping Ye
Journal:  Front Med       Date:  2013-03-09       Impact factor: 4.592

2.  Hyperinsulinemia induces insulin resistance and immune suppression via Ptpn6/Shp1 in zebrafish.

Authors:  Rubén Marín-Juez; Susanne Jong-Raadsen; Shuxin Yang; Herman P Spaink
Journal:  J Endocrinol       Date:  2014-06-05       Impact factor: 4.286

3.  Assessment of Insulin Sensitivity and its Convalescence with Dietary Rehabilitation in Undernourished Rural West Bengal Population.

Authors:  Nimmy K Francis; Harpreet Singh Pawar; Anirban Mitra; Analava Mitra
Journal:  J Clin Diagn Res       Date:  2017-05-01

4.  Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature.

Authors:  Thomas Walther; Gerd Wallukat; Alexander Jank; Sabine Bartel; Heinz-Peter Schultheiss; Renaldo Faber; Holger Stepan
Journal:  Hypertension       Date:  2005-10-31       Impact factor: 10.190

5.  The morphology and topographic distribution of AII amacrine cells in the cat retina.

Authors:  D I Vaney
Journal:  Proc R Soc Lond B Biol Sci       Date:  1985-06-22

6.  Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor.

Authors:  Mingming Wei; Chengrui Zhao; Suli Zhang; Li Wang; Huirong Liu; Xinliang Ma
Journal:  J Immunol Res       Date:  2016-01-20       Impact factor: 4.818

7.  The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia.

Authors:  Roxanna A Irani; Yujin Zhang; Sean C Blackwell; Cissy Chenyi Zhou; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

Review 8.  Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.

Authors:  Andreas L Birkenfeld; Gerald I Shulman
Journal:  Hepatology       Date:  2014-02       Impact factor: 17.425

Review 9.  Current thoughts on maternal nutrition and fetal programming of the metabolic syndrome.

Authors:  Bonnie Brenseke; M Renee Prater; Javiera Bahamonde; J Claudio Gutierrez
Journal:  J Pregnancy       Date:  2013-02-14

10.  Aluminum Toxicity-Induced Alterations of Leaf Proteome in Two Citrus Species Differing in Aluminum Tolerance.

Authors:  Huan Li; Lin-Tong Yang; Yi-Ping Qi; Peng Guo; Yi-Bin Lu; Li-Song Chen
Journal:  Int J Mol Sci       Date:  2016-07-21       Impact factor: 5.923

View more
  3 in total

1.  Reduced Expression of PLCXD3 Associates With Disruption of Glucose Sensing and Insulin Signaling in Pancreatic β-Cells.

Authors:  Hayat Aljaibeji; Debasmita Mukhopadhyay; Abdul Khader Mohammed; Sarah Dhaiban; Mahmood Y Hachim; Noha M Elemam; Nabil Sulaiman; Albert Salehi; Jalal Taneera
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-06       Impact factor: 5.555

Review 2.  An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms.

Authors:  Melvin R Hayden
Journal:  Cells       Date:  2020-11-13       Impact factor: 6.600

Review 3.  Mechanisms of Post-Pancreatitis Diabetes Mellitus and Cystic Fibrosis-Related Diabetes: A Review of Preclinical Studies.

Authors:  Eleonóra Gál; Jurij Dolenšek; Andraž Stožer; László Czakó; Attila Ébert; Viktória Venglovecz
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-10       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.